SCHEMBL13145286

SCHEMBL13145286

CC(C)c1ccc(CCOCc2ccccc2)s1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
ALOX5 P09917 1/20 0.37
WRN Q14191 1/20 0.35
NAAA Q02083 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
VCP P55072 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA7 P43166 2/20 0.34
CA9 Q16790 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13145489 0.86 TSHR (0.50) TSHRALOX5VCPCA1CA2
SCHEMBL13763027 0.80 TP53 (0.50) TDP1L3MBTL1TSHRNAAASMN1; SMN2
SCHEMBL27420724 0.75 ALOX5 (0.57) TDP1L3MBTL1ALOX5WRNSMN1; SMN2
SCHEMBL13145294 0.75 TDP1 (0.40) TDP1L3MBTL1TSHRNAAAHTT
SCHEMBL12809389 0.73 NR4A2 (0.48) TSHRHTTSMN1; SMN2ALDH1A1POLB
SCHEMBL1066576 0.70 TSHR (0.67) TDP1L3MBTL1TSHRNAAASMN1; SMN2
SCHEMBL13145482 0.70 TSHR (0.41) TDP1L3MBTL1TSHRNAAAHTT
SCHEMBL12809089 0.69 TSHR (0.48) TDP1L3MBTL1TSHRNAAASMN1; SMN2
SCHEMBL13145274 0.69 TSHR (0.40) TDP1L3MBTL1TSHRNAAAHTT
Water SCHEMBL28780406 0.68 TSHR (0.64) TDP1L3MBTL1TSHRNAAAHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795261-B2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists JANSSEN PHARMACEUTICA NV (BE) 2010-09-14 US disclosed
US-7795261-B2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists JANSSEN PHARMACEUTICA NV (BE) 2010-09-14 US disclosed
US-7572786-B2 Irritable bowel syndrome; tachykinin mediated condition such as schizophrenia, emesis, anxiety, depression, irritable bowel syndrome, circadian rhythm disturbances, pain, neurogenic inflammation, asthma, micturition disorder or nociception JANSSEN PHARMACEUTICA, N.V. (BE) 2009-08-11 US disclosed